182 related articles for article (PubMed ID: 27147149)
1. Quantitative assessment of iron deposition in Parkinson's disease using enhanced T2 star-weighted angiography.
Ji S; Zhang S; Mao Z; Han H; Yang Q; Zhu W; Zhu S; Xue Z
Neurol India; 2016; 64(3):428-35. PubMed ID: 27147149
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
3. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
[TBL] [Abstract][Full Text] [Related]
6. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
[TBL] [Abstract][Full Text] [Related]
7. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
8. Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson's disease patients with type 2 diabetes mellitus.
Li W; Gao B; Du W; Jiang Y; Yang J; Hu R; Liu Y; Liu N; Zhang Y; Song Q; Miao Y
Front Aging Neurosci; 2022; 14():975390. PubMed ID: 36177478
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
[TBL] [Abstract][Full Text] [Related]
10. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study.
Guan X; Xuan M; Gu Q; Xu X; Huang P; Wang N; Shen Z; Xu J; Luo W; Zhang M
J Magn Reson Imaging; 2017 May; 45(5):1335-1342. PubMed ID: 27545971
[TBL] [Abstract][Full Text] [Related]
11. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
[TBL] [Abstract][Full Text] [Related]
12. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
13. The protective role of cigarette smoking against Parkinson's disease via moderation of the interaction between iron deposition in the nigrostriatal pathway and clinical symptoms.
Gu Q; Liu X; Zeng Q; Guan X; Zhou C; Guo T; Zhang B; Zhang M
Quant Imaging Med Surg; 2022 Jul; 12(7):3603-3624. PubMed ID: 35782263
[TBL] [Abstract][Full Text] [Related]
14. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study.
Shin C; Lee S; Lee JY; Rhim JH; Park SW
J Korean Med Sci; 2018 Mar; 33(13):e96. PubMed ID: 29573246
[TBL] [Abstract][Full Text] [Related]
15. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.
Zhang J; Zhang Y; Wang J; Cai P; Luo C; Qian Z; Dai Y; Feng H
Brain Res; 2010 May; 1330():124-30. PubMed ID: 20303339
[TBL] [Abstract][Full Text] [Related]
16. Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease.
Wu G; Shen YJ; Huang MH; Xing Z; Liu Y; Chen J
AJR Am J Roentgenol; 2016 Feb; 206(2):385-9. PubMed ID: 26797368
[TBL] [Abstract][Full Text] [Related]
17. Clinical MRI for iron detection in Parkinson's disease.
Rossi M; Ruottinen H; Soimakallio S; Elovaara I; Dastidar P
Clin Imaging; 2013; 37(4):631-6. PubMed ID: 23522789
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI.
Wu SF; Zhu ZF; Kong Y; Zhang HP; Zhou GQ; Jiang QT; Meng XP
Eur Rev Med Pharmacol Sci; 2014; 18(18):2605-8. PubMed ID: 25317792
[TBL] [Abstract][Full Text] [Related]
19. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
